CD4+CD25highFOXP3+ regulatory T cells in peripheral blood are primarily of effector memory phenotype.

Suppr

超能文献

作者信息

Beyer Marc, Schultze Joachim L

出版信息

J Clin Oncol. 2007 Jun 20;25(18):2628-30; author reply 2630-2. doi: 10.1200/JCO.2006.08.0192.

DOI:10.1200/JCO.2006.08.0192

PMID:17577047

Abstract

摘要

相似文献

CD4+CD25highFOXP3+ regulatory T cells in peripheral blood are primarily of effector memory phenotype.

J Clin Oncol. 2007 Jun 20;25(18):2628-30; author reply 2630-2. doi: 10.1200/JCO.2006.08.0192.

Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma.

J Clin Oncol. 2006 Mar 1;24(7):1169-77. doi: 10.1200/JCO.2005.03.6830.

Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.

Clin Cancer Res. 2000 Apr;6(4):1267-72.

Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma.

J Immunother. 2005 Nov-Dec;28(6):582-92. doi: 10.1097/01.cji.0000175468.19742.10.

High-dose IL-2 for metastatic renal cell carcinoma: can the first antitumor immunotherapy be reinvented?

Immunotherapy. 2014;6(9):955-8. doi: 10.2217/imt.14.78.

Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer.

Clin Cancer Res. 2007 Apr 1;13(7):2100-8. doi: 10.1158/1078-0432.CCR-06-1662.

Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.

Clin Cancer Res. 2006 Oct 1;12(19):5850-8. doi: 10.1158/1078-0432.CCR-06-1159.

Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas.

Cancer Res. 2009 Nov 1;69(21):8412-9. doi: 10.1158/0008-5472.CAN-09-0852. Epub 2009 Oct 20.

Systemic immune tuning in renal cell carcinoma: favorable prognostic impact of TGF-β1 mRNA expression in peripheral blood mononuclear cells.

J Immunother. 2011 Jan;34(1):113-9. doi: 10.1097/CJI.0b013e3181fb6580.

High-dose interleukin-2 in metastatic disease: renal cell carcinoma and melanoma.

Oncology (Williston Park). 2002 Nov;16(11 Suppl 13):3.

引用本文的文献

HIF1α-regulated glycolysis promotes activation-induced cell death and IFN-γ induction in hypoxic T cells.

Nat Commun. 2024 Oct 30;15(1):9394. doi: 10.1038/s41467-024-53593-8.

Effector memory-type regulatory T cells display phenotypic and functional instability.

Sci Adv. 2024 Sep 6;10(36):eadn3470. doi: 10.1126/sciadv.adn3470. Epub 2024 Sep 4.

HIF1α-glycolysis engages activation-induced cell death to drive IFN-γ induction in hypoxic T cells.

Res Sq. 2024 Jan 12:rs.3.rs-3830704. doi: 10.21203/rs.3.rs-3830704/v1.

Prognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patients.

Sci Rep. 2016 Dec 15;6:39247. doi: 10.1038/srep39247.

Fas-Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis.

Front Immunol. 2016 Sep 27;7:382. doi: 10.3389/fimmu.2016.00382. eCollection 2016.

Inducing and Administering Tregs to Treat Human Disease.

Front Immunol. 2016 Jan 22;6:654. doi: 10.3389/fimmu.2015.00654. eCollection 2015.

The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status.

Haematologica. 2014 Oct;99(10):1605-10. doi: 10.3324/haematol.2014.105866. Epub 2014 Jun 27.

Molecular mechanisms of treg-mediated T cell suppression.

Front Immunol. 2012 Mar 21;3:51. doi: 10.3389/fimmu.2012.00051. eCollection 2012.

In vivo expansion of naïve CD4+ CD25(high) FOXP3+ regulatory T cells in patients with colorectal carcinoma after IL-2 administration.

PLoS One. 2012;7(1):e30422. doi: 10.1371/journal.pone.0030422. Epub 2012 Jan 20.

Comparative approach to define increased regulatory T cells in different cancer subtypes by combined assessment of CD127 and FOXP3.

Clin Dev Immunol. 2011;2011:734036. doi: 10.1155/2011/734036. Epub 2011 Aug 28.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验